Tradestie Institutional Equity Comparison Engine
APUS vs ONEN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
APUS Overall Edge
APUS Captures Institutional Edge (2โ1 Pillars ยท 7โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Apimeds Pharmaceuticals US, Inc. (APUS) driven by superior Growth & Margin, Momentum & Technical while ONEN counters with relative strength in Options & Structure. Fundamentally, APUS trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ONEN at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, APUS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against ONEN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
APUS N/M vs ONEN N/M Fwd P/E
Growth & Margin Winner
APUS
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner
APUS
1Y -15.8% vs -84.7% ยท 52W Pos 11% vs 2%
Options & Structure Winner
ONEN
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
APUS
NYSE American
Apimeds Pharmaceuticals US, Inc.
Pharmaceutical Preparations
$1.60
-8.05% 1D
Market Cap
$3.2M
1M Return
-49.37%
1Y Return
-15.79%
Forward P/E
N/M
Unified AI Score
44.9 / 100
HOLD
Tech 35.0
Fund 43.0
Flow 50.0
Mom 55.0
ONEN
US Equity
ONEN
Institutional Equity
$0.53
+9.8% 1D
Market Cap
N/A
1M Return
-59.53%
1Y Return
-84.72%
Forward P/E
N/M
Unified AI Score
48.8 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
APUS -15.79%
ONEN -84.72%
Spread: +17.24 pp (APUS Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
APUS TTM Op. Margin: 0.0%
ONEN TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on APUS vs ONEN. Trailing 12-month operating profitability (APUS 0.0% vs ONEN N/A) and valuation multiples (APUS N/M vs ONEN N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | APUS | ONEN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.2M | N/A | Larger Scale | APUS |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | N/A | Higher Growth | APUS |
| Operating Margin (TTM) Profitability | 0.0% | N/A | Higher Margin | APUS |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | APUS |
| Return on Equity (ROE) Capital Efficiency | 0.0% | N/A | Higher ROE | APUS |
| 52-Week Range Position Momentum | 11% ($1โ$10) | 2% ($0โ$4) | Stronger Trend | APUS |
| Beta / 30D Volatility Risk Regime | 3.20ฮฒ ยท 72% Vol | -0.18ฮฒ ยท 201% Vol | Lower Realized Risk | APUS |
| Unified Institutional Score Composite Signal | 44.9 / 100 (HOLD) | 48.8 / 100 (HOLD) | Higher Composite | ONEN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full APUS vs ONEN Buy Guide
APUS
BREAKDOWN
80d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ONEN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither APUS nor ONEN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.